Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/183633
Authors: 
Stojchevska, Ivana
Baftijari, Agon
Year of Publication: 
2015
Citation: 
[Title:] Proceedings of the ENTRENOVA - ENTerprise REsearch InNOVAtion Conference, Kotor, Montengero, 10-11 September 2015 [ISSN:] 2706-4735 [Volume:] 1 [Pages:] 72-79
Abstract: 
Most of the countries worldwide have strong regulations on drug markets, in order to cope with the rising costs of health care. On the other hand, the regulations violate the incentives for investment in pharmaceutical R&D projects. Thus, in order to stimulate R&D activity, and at the same time to regulate pharmaceutical market, every government is obligated to create balanced reforms for pharmaceutical market. This paper presents the policies for fostering innovations and regulations in the pharmaceutical market in R. Bulgaria and R. Macedonia. The comparison with the regulations and stimulations for pharmaceutical market in USA and other EU countries will help in creating the most corresponding programme, both for the customers and pharmaceutical companies.
Subjects: 
government policy
pharmaceutical pricing
R&D projects
pharmaceutical industry
JEL: 
I18
L51
Creative Commons License: 
https://creativecommons.org/licenses/by-nc/4.0/
Document Type: 
Conference Paper

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.